Oncodrone to progress prostate cancer drug with €2.5m grant
25 August 2015 | By Victoria White
Oncodrone, the anti-cancer company based in Nijmegen, has been granted a € 2,5 million Eurostars grant for the development of its lead drug OCD155...
List view / Grid view
25 August 2015 | By Victoria White
Oncodrone, the anti-cancer company based in Nijmegen, has been granted a € 2,5 million Eurostars grant for the development of its lead drug OCD155...
18 August 2015 | By Victoria White
Cancer Research UK will fund preclinical research evaluating the efficacy of Imprime PGG in combination with monoclonal antibody (MAb) therapies...
18 August 2015 | By Victoria White
Testing for genetic risk factors could improve treatment for myeloma patients by identifying those at risk of developing more aggressive disease...
17 August 2015 | By Victoria White
Researchers from have identified the molecular mechanism that an adhesion protein of H. pylori uses to attach to stomach ulcers...
17 August 2015 | By Victoria White
Researchers supported by the NIH have discovered a type of cell, known as hybrid hepatocytes, essential to regeneration of the liver...
12 August 2015 | By Author: Katie Sadler, Digital Content Producer, Drug Target Review
Research carried out by University of California San Francisco (UCSF) has revealed ion channel blocking drugs could play a part in cancer therapy. The common class of channel blocking drugs, which are used to treat cardiac, neurological, and psychiatric disorders, could prove to be beneficial in cancer treatment according to…
5 August 2015 | By Victoria White
Two research projects involving ADXS-PSA, which is being developed for prostate cancer, have been selected for 2015 Movember Foundation-PCF Challenge Awards...
3 August 2015 | By Victoria White
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for immune cells, leaving them too drained to fight the disease...
31 July 2015 | By Victoria White
Researchers identify a pair of master regulators that control the fate of follicular helper T (TFH) cells - a finding that could improve vaccine design...
27 July 2015 | By Victoria White
Genetic aberrations have been seen as the main cause of almost all cancer but new research shows cancer can be caused solely by protein imbalances...
23 July 2015 | By Victoria White
Scientists have developed MAGI, an open-source web application, to help researchers and clinicians explore the genetic underpinnings of cancer...
23 July 2015 | By Victoria White
CCT245737, a new drug that blocks cancer’s escape route from chemotherapy, could be used to treat deadly lung and pancreatic cancers...
22 July 2015 | By Victoria White
An international panel of leading scientists has launched a new TripAdvisor-style website aimed at helping researchers choose better-quality chemical probes...
21 July 2015 | By Victoria White
University of Queensland researchers have discovered thousands of new peptide toxins hidden deep within the venom of just one type of cone snail...
16 July 2015 | By Victoria White
Researchers have discovered two chemical compounds that effectively stop the growth of brain cancer cells and breast tumours by inhibiting the Stat3 protein...